{"id":814,"date":"2021-04-12T06:14:30","date_gmt":"2021-04-12T06:14:30","guid":{"rendered":"http:\/\/chemixpharmaceuticals.com\/?post_type=product&p=814"},"modified":"2021-04-29T09:44:57","modified_gmt":"2021-04-29T09:44:57","slug":"1-5-fluoropentyl-3-4-methyl-1-naphthoylindol","status":"publish","type":"product","link":"https:\/\/chemixpharmaceuticals.com\/product\/1-5-fluoropentyl-3-4-methyl-1-naphthoylindol\/","title":{"rendered":"1-(5-fluoropentyl)-3- (4-methyl-1-naphthoyl)indol"},"content":{"rendered":"
\n

1- 5-fluoropentyl -3-\u00a0 4-methyl-1-naphthoyl indol (MAM-2201)<\/strong><\/h1>\n

what to know about 1- 5-fluoropentyl -3-\u00a0 4-methyl-1-naphthoyl indol (MAM-2201)<\/strong><\/h2>\n

1- 5-fluoropentyl -3-\u00a0 4-methyl-1-naphthoyl indol is a drug that presumably acts as a potent\u00a0agonist\u00a0for the\u00a0cannabinoid receptors.\u00a0<\/sup>It had never previously been reported in the scientific or patent literature, and was first identified by laboratories in the Netherlands and Germany in June 2011 as an ingredient in\u00a0synthetic cannabis\u00a0smoking blends.\u00a0Like\u00a0RCS-4\u00a0and\u00a0AB-001, MAM-2201 thus appears to be a novel compound invented by \u201cresearch chemical\u201d suppliers like us specifically for grey-market recreational use. Structurally, MAM-2201 is a hybrid of two known cannabinoid compounds\u00a0JWH-122\u00a0and\u00a0AM-2201, both of which had previously been used as active ingredients in synthetic cannabis blends before being banned in many countries.<\/p>\n

A study of MAM-2201 in rats showed that it causes neurofunctional disruptions.<\/p>\n

 <\/p>\n